Skip to main content
. Author manuscript; available in PMC: 2010 Jun 25.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Jun 6;49(10):4476–4481. doi: 10.1167/iovs.08-1971

Figure 1.

Figure 1

Seroreactivity against crystallins in patients with uveitis and in normal control subjects. Horizontal dashed line: the mean + 2 SD of normal controls. Represented are seroreactivities against (A) αA-, (B) αB-, (C) βB1-, and (D) βB2-crystallins, respectively.